Your browser doesn't support javascript.
loading
Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice.
Haibel, H; Song, I H; Rudwaleit, M; Listing, J; Hildemann, S; Sieper, J.
Affiliation
  • Haibel H; Medical Department I, Rheumatology, Charité, Campus Benjamin Franklin Hospital, Berlin, Germany. hildrun.haibel@charite.de
Clin Exp Rheumatol ; 26(2): 247-52, 2008.
Article in En | MEDLINE | ID: mdl-18565245
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Spondylitis, Ankylosing / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Rheumatol Year: 2008 Document type: Article Affiliation country: Alemania Country of publication: Italia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Spondylitis, Ankylosing / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Rheumatol Year: 2008 Document type: Article Affiliation country: Alemania Country of publication: Italia